Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer

Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer

Saved in:

Bibliographic Details
Main Authors:	Martin Stockler, Yu Yang Soon, Chee Khoon Lee, Teng Hwee Tan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-07-01
Series:	BMJ Oncology
Online Access:	https://bmjoncology.bmj.com/content/3/1/e000227.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Highlights on immune checkpoint inhibitors in non–small cell lung cancer
by: Meng Shen, et al.
Published: (2017-03-01)

Research Progress of Immune Checkpoint Inhibitors Combined with Anti-Angiogenic Drugs in Treatment of Advanced Non-Small Cell Lung Cancer
by: Aiju ZENG, et al.
Published: (2025-06-01)

Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors
by: Marco Meazza Prina, et al.
Published: (2024-12-01)

Circulating predictive markers of immune checkpoint inhibitors in non-small cell lung cancer
by: A. A. Musaelyan, et al.
Published: (2021-11-01)

Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
by: O. P. Kolesnik, et al.
Published: (2021-06-01)

Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study
by: Fu-Xiao Li, et al.
Published: (2025-03-01)

Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01)

Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01)

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
by: Kartik Sehgal, et al.
Published: (2020-05-01)

Efficacy analysis of endostar combined with chemoradiotherapy and immune checkpoint inhibitors in locally advanced non-small cell lung cancer
by: Bo Li, et al.
Published: (2025-07-01)

Characteristics of the gut microbiota in patients with advanced non-small cell lung cancer who responded to immune checkpoint inhibitors
by: Hideyuki Komatsu, et al.
Published: (2025-07-01)

Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01)

Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer
by: Ziwei Wang, et al.
Published: (2025-05-01)

Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
by: Martina Catalano, et al.
Published: (2024-11-01)

Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
by: Yusuke Hamakawa, et al.
Published: (2025-01-01)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024-12-01)

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
by: Wenli Cao, et al.
Published: (2025-04-01)

Research progress of immune checkpoint inhibitors in the treatment of acral melanoma
by: QIAN Jiajia, RUAN Cong, LIU Jiyong, XU Rui
Published: (2025-07-01)

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer
by: Jia-Yi Deng, et al.
Published: (2025-04-01)

Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors
by: Luigi Liguori, et al.
Published: (2025-08-01)

Advances in immune checkpoint inhibitor therapy for breast cancer: research progress and future directions
by: ZENG Cheng, WANG Yuanyi, WANG Jiani, MA Fei
Published: (2025-02-01)

Salvage Pulmonary Resection After Immune Checkpoint or Tyrosine Kinase Inhibitor Therapy for Initially Unresectable Non-Small-Cell Lung Cancer: A Systematic Review
by: Vasile Gaborean, et al.
Published: (2025-06-01)

Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment
by: Liang Zhang, et al.
Published: (2020-05-01)

Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer
by: Yu Tanaka, et al.
Published: (2025-01-01)

Onset and progression of atherosclerosis in patients with melanoma treated with immune checkpoint inhibitors
by: Ron H J Mathijssen, et al.
Published: (2025-04-01)

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors
by: AN Tianqi, TIAN Jianhui, ZHOU Yiyang, LUO Bin, QUE Zujun, LIU Yao, YU Pan, ZHAO Ruihua, YANG Yun
Published: (2025-03-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Prognostic analysis and association of the systemic immune-inflammatory index with immune checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer
by: Mengyao Cai, et al.
Published: (2025-06-01)

Impact of antiemetic steroid use on survival in small cell lung cancer patients receiving immune checkpoint inhibitors and chemotherapy
by: Soh Mee Park, et al.
Published: (2025-07-01)

The combination of chemotherapy and immune checkpoint inhibitors in recurrent extensive-stage small cell lung cancer: a case report
by: Chunxiu Hu, et al.
Published: (2025-07-01)

Evaluating the safety and efficacy of combination immune checkpoint inhibitors and chemotherapy treatment in extensive-stage small cell lung cancer
by: Yalin Xie, et al.
Published: (2025-05-01)

Risk factors for checkpoint inhibitor pneumonitis in lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Xiaoqing Zhou, et al.
Published: (2025-05-01)

Immune Checkpoint Inhibitors in Melanoma Treatment: Advances and Obstacles
by: A. V. Sultanbaev
Published: (2025-04-01)

Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
by: Jiafan Liu, et al.
Published: (2025-04-01)

Immune Checkpoint Inhibitor‐Based Therapy as the First‐Line Treatment for Advanced Non‐Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives
by: Xingxiang Pu, et al.
Published: (2025-06-01)

Combining immune checkpoint inhibitors with thoracic radiotherapy enhances outcomes in advanced non-small-cell lung cancer: a real-world study
by: Yao Zou, et al.
Published: (2025-08-01)

Case Report: Development of severe inflammatory orbitopathy after immune checkpoint inhibitor initiation
by: Samantha Madala, et al.
Published: (2025-06-01)

Colonic Lung Cancer Metastasis in Vedolizumab-Treated Immune Checkpoint Inhibitor Colitis
by: Sean S. Davis, et al.
Published: (2020-07-01)

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
by: Ling Yang, et al.
Published: (2025-08-01)

The association of immune-inflammation indices at multiple time points with treatment response and survival in advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors
by: Yaqing Li, et al.
Published: (2025-05-01)